Location of Repository

Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?

By L. Yu. Morgunov

Abstract

<p align="left">Diagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. Octreotide in patients with neuroendocrine tumors remains a drug with proven efficacy that can suppress the clinical symptoms of carcinoid syndrome and has antiproliferative activity, which can improve the quality of life and prolong survival.<strong></strong></p

Topics: октреотид, аналоги соматостатина, нейроэндокринные опухоли, карциноидный синдром, Medicine, R
Publisher: QUASAR, LLC
Year: 2015
OAI identifier: oai:doaj.org/article:e8f9d37a025f48838c97bad9c53ce55b
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2410-1893 (external link)
  • https://doaj.org/toc/2409-2231 (external link)
  • http://www.rpmj.ru/rpmj/articl... (external link)
  • https://doaj.org/article/e8f9d... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.